|
시장보고서
상품코드
2055302
당뇨병 진단 시장 : 제품 유형별, 검사 유형별, 진단 기술별, 당뇨병 유형별, 최종사용자별Diabetes Diagnostics Market, By Product Type, By Testing Type, By Diagnostic Technology, By Diabetes Type, By End User |
||||||
당뇨병 진단 시장은 2026년 369억 8,000만 달러로 추정되며, 2033년까지 637억 9,000만 달러에 이를 전망입니다. 또한 2026-2033년 CAGR 8.1%를 나타낼 것으로 예측됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 369억 8,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 8.10% | 2033년 시장 규모 예측 : | 637억 9,000만 달러 |
세계 당뇨병 진단 시장은 전 세계 수억 명의 사람들에게 영향을 미치는 만성 대사성 질환인 당뇨병의 검출, 모니터링 및 관리에 중점을 둔 매우 중요한 의료 분야입니다. 이 시장에는 당뇨병 전단계 환자 선별, 각종 당뇨병 진단, 그리고 당뇨병 환자의 혈당 수치를 지속적으로 모니터링하기 위한 다양한 진단 도구, 기술 및 조사 방법이 포함됩니다.
진단 분야에는 기존의 혈당 측정기, 첨단 연속 혈당 모니터링 시스템, 헤모글로빈 A1c 검사 기기, 케톤체 검사 스트립, 그리고 새롭게 등장한 현장 진단(POCT) 솔루션이 포함됩니다. 앉아 있는 생활 습관, 비만, 고령화, 식생활의 변화로 인해 전 세계적으로 당뇨병 유병률이 증가하고 있어, 정확하고 효율적이며 사용하기 편리한 진단 솔루션에 대한 수요가 계속 높아지고 있습니다. 의료진, 환자, 간병인들은 실시간 모니터링 기능, 정확도 향상, 그리고 연결 기능의 강화가 갖춰진 첨단 진단 기술에 대한 의존도를 높이고 있습니다. 이 시장은 병원 및 진단실험실부터 재택 간호 환경에 이르기까지 다양한 의료 현장에 대응하고 있으며, 전 세계 다양한 인구 집단에서 합병증을 예방하고 환자의 예후를 개선하기 위해 당뇨병의 조기 발견과 효과적인 관리를 촉진하고 있습니다.
시장 역학
세계 당뇨병 진단 시장은 견조한 성장세를 뒷받침하는 몇 가지 주요 촉진요인에 힘입어 성장하고 있으며, 그 주된 요인은 생활 방식의 변화, 도시화, 그리고 모든 연령대에서 비만율이 증가함에 따라 전 세계 당뇨병, 특히 2형 당뇨병의 유병률이 우려할 만한 수준으로 상승하고 있다는 점입니다. 비침습적 혈당 모니터링 시스템, 스마트폰 연동 기기, 인공지능(AI)을 활용한 진단 도구 개발 등 진단 기기 분야의 기술적 진보는 정확도, 편의성 및 환자의 치료 순응도를 향상시킴으로써 시장 확대를 크게 촉진하고 있습니다.
신흥국에서의 당뇨병 인식 제고, 선별 검사 프로그램, 의료 인프라 확충을 촉진하기 위한 정부의 이니셔티브는 막대한 시장 기회를 창출하고 있습니다. 한편, 전 세계적인 고령화는 정기적인 진단 모니터링이 필요한 환자층을 자연스럽게 늘리고 있습니다. 그러나 시장에는 뚜렷한 제약도 존재합니다. 첨단 진단 장비와 지속적인 모니터링 시스템에 따른 높은 비용은 특히 저소득 지역이나 무보험자층에서 의료 서비스 이용을 제한하는 요인이 되고 있습니다. 의료기기 승인과 관련된 엄격한 규제 요건은 제조업체에게 개발 기간의 장기화와 막대한 투자 장벽을 초래하고 있습니다. 또한, 개발도상국의 의료 인프라 부족은 질병 유병률이 높음에도 불구하고 시장 침투를 제한하고 있습니다. 또한, 네트워크 연결형 진단 기기의 데이터 개인정보 보호 및 사이버 보안에 대한 우려도 보급을 가로막는 과제로 대두되고 있습니다.
이러한 제약이 있음에도 불구하고, 재택 진단 솔루션에 대한 수요 증가, 원격 의료 플랫폼과 진단 기기의 통합, 그리고 조기 발견과 지속적인 모니터링을 중시하는 예방 의료에 대한 관심 확대를 통해 큰 기회가 창출되고 있습니다. 이로 인해 비용 대비 효과가 높고 정확하며 사용자 친화적인 진단 솔루션을 개발하는 혁신적인 기업들에게 수익성 높은 전망이 열리고 있습니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 주요 항목(기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적, 전략)을 바탕으로 전 세계 당뇨병 진단 시장의 주요 기업 프로파일을 작성하였습니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 기종 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 당뇨병 진단 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 당뇨병 진단 시장을 분석하는 데 활용되는 다양한 전략 매트릭스를 통해 의사결정을 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 당뇨병 진단 시장 : 제품 유형별, 2021년-2033년
제5장 세계의 당뇨병 진단 시장 : 테스트 유형별, 2021년-2033년
제6장 세계의 당뇨병 진단 시장 : 진단 기술별, 2021년-2033년
제7장 세계의 당뇨병 진단 시장 : 당뇨병 유형별, 2021년-2033년
제8장 세계의 당뇨병 진단 시장 : 최종사용자별, 2021년-2033년
제9장 세계의 당뇨병 진단 시장 : 유통 채널별, 2021년-2033년
제10장 세계의 당뇨병 진단 시장 : 지역별, 2021년-2033년
제11장 경쟁 구도
제12장 애널리스트의 제안
제13장 참고 문헌 및 조사 방법
LSH 26.06.23Diabetes Diagnostics Market is estimated to be valued at USD 36.98 Bn in 2026 and is expected to reach USD 63.79 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 36.98 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.10% | 2033 Value Projection: | USD 63.79 Bn |
The global diabetes diagnostics market represents a critical healthcare segment focused on the detection, monitoring, and management of diabetes mellitus, a chronic metabolic disorder affecting hundreds of millions worldwide. This market encompasses a comprehensive range of diagnostic tools, technologies, and testing methodologies designed to identify pre-diabetic conditions, diagnose various types of diabetes, and continuously monitor blood glucose levels in diabetic patients.
The diagnostic landscape includes traditional glucose monitoring devices, advanced continuous glucose monitoring systems, hemoglobin A1c testing equipment, ketone testing strips, and emerging point-of-care testing solutions. With the rising global prevalence of diabetes driven by sedentary lifestyles, obesity, aging populations, and dietary changes, the demand for accurate, efficient, and user-friendly diagnostic solutions continues to escalate. Healthcare providers, patients, and caregivers increasingly rely on sophisticated diagnostic technologies that offer real-time monitoring capabilities, improved accuracy, and enhanced connectivity features. The market serves diverse healthcare settings ranging from hospitals and diagnostic laboratories to home-care environments, facilitating early detection and effective management of diabetes to prevent complications and improve patient outcomes across different demographic segments worldwide.
Market Dynamics
The global diabetes diagnostics market is propelled by several key drivers that sustain its robust growth trajectory, with the primary catalyst being the alarming rise in diabetes prevalence globally, particularly Type 2 diabetes, driven by lifestyle changes, urbanization, and increasing obesity rates across all age groups. Technological advancements in diagnostic equipment, including the development of non-invasive glucose monitoring systems, smartphone-integrated devices, and artificial intelligence-powered diagnostic tools, significantly enhance market expansion by improving accuracy, convenience, and patient compliance.
Government initiatives promoting diabetes awareness, screening programs, and healthcare infrastructure development in emerging economies create substantial market opportunities, while aging populations worldwide naturally increase the patient pool requiring regular diagnostic monitoring. However, the market faces notable restraints including high costs associated with advanced diagnostic equipment and continuous monitoring systems, which limit accessibility particularly in low-income regions and among uninsured populations. Stringent regulatory requirements for medical device approvals create lengthy development timelines and substantial investment barriers for manufacturers, while limited healthcare infrastructure in developing countries restricts market penetration despite high disease prevalence. Additionally, concerns regarding data privacy and cybersecurity in connected diagnostic devices pose challenges for widespread adoption.
Despite these constraints, significant opportunities emerge through the growing demand for home-based diagnostic solutions, integration of telemedicine platforms with diagnostic devices, and the expanding focus on preventive healthcare measures that emphasize early detection and continuous monitoring, creating lucrative prospects for innovative companies developing cost-effective, accurate, and user-friendly diagnostic solutions.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global diabetes diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include leading manufacturers and technology providers in the diabetes diagnostics space.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global diabetes diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diabetes diagnostics market.
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Blood Glucose Meters
- Continuous Glucose Monitoring (CGM) Systems
- Testing Strips
- Lancets and Lancing Devices
- HbA1c Testing Kits
- Ketone Testing Kits
- Insulin Dose Calculators/Insulin Delivery Devices
- Others (e.g., smart wearables, emerging digital diagnostic tools)
- Testing Type Insights (Revenue, USD Bn, 2021 - 2033)
- Self-Monitoring Blood Glucose (SMBG) Tests
- Laboratory-Based Tests
- Point-of-Care (POC) Tests
- Diagnostic Technology Insights (Revenue, USD Bn, 2021 - 2033)
- Electrochemical Biosensors
- Optical Sensors
- Enzymatic Assays
- Immunoassays
- Microfluidic Technology
- Others (e.g., next-gen nanotechnology-based diagnostics)
- Diabetes Type Insights (Revenue, USD Bn, 2021 - 2033)
- Type 1 Diabetes
- Type 2 Diabetes
- Gestational Diabetes
- Prediabetes/Screening
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals and Clinics
- Diagnostic Laboratories
- Home Care Settings
- Ambulatory Surgical Centers (ASCs)
- Others (Research Institutes and Academic Centers)
- Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Abbott
- Roche Diagnostics
- Dexcom
- Medtronic
- LifeScan
- Ascensia Diabetes Care
- ARKRAY
- i-SENS
- Sinocare
- Bio-Rad Laboratories
- Tosoh Bioscience
- Siemens Healthineers
- Trinity Biotech
- EKF Diagnostics
- Senseonics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Diabetes Diagnostics Market, By Product Type
- Global Diabetes Diagnostics Market, By Testing Type
- Global Diabetes Diagnostics Market, By Diagnostic Technology
- Global Diabetes Diagnostics Market, By Diabetes Type
- Global Diabetes Diagnostics Market, By End User
- Global Diabetes Diagnostics Market, By Distribution Channel
- Global Diabetes Diagnostics Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Diabetes Diagnostics Market, By Product Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Blood Glucose Meters
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Continuous Glucose Monitoring (CGM) Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Testing Strips
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Lancets and Lancing Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- HbA1c Testing Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ketone Testing Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Insulin Dose Calculators/Insulin Delivery Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (e.g., smart wearables, emerging digital diagnostic tools)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Diabetes Diagnostics Market, By Testing Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Self-Monitoring Blood Glucose (SMBG) Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Laboratory-Based Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Point-of-Care (POC) Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Diabetes Diagnostics Market, By Diagnostic Technology, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Electrochemical Biosensors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Optical Sensors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Enzymatic Assays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Immunoassays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Microfluidic Technology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (e.g., next-gen nanotechnology-based diagnostics)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Diabetes Diagnostics Market, By Diabetes Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Type 1 Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Type 2 Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Gestational Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Prediabetes/Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Diabetes Diagnostics Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ambulatory Surgical Centers (ASCs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Research Institutes and Academic Centers)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Diabetes Diagnostics Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global Diabetes Diagnostics Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Testing Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnostic Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diabetes Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Testing Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnostic Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diabetes Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Testing Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnostic Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diabetes Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Testing Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnostic Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diabetes Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Testing Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnostic Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diabetes Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Testing Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnostic Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diabetes Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Abbott
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Dexcom
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- LifeScan
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ascensia Diabetes Care
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ARKRAY
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- i-SENS
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sinocare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Tosoh Bioscience
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Trinity Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- EKF Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Senseonics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
